Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78531874 | 7853187 | 4 | F | 2001 | 20160628 | 20110314 | 20160706 | EXP | US-ASTRAZENECA-2011SE11840 | ASTRAZENECA | 66.00 | YR | F | Y | 47.20000 | KG | 20160706 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78531874 | 7853187 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
78531874 | 7853187 | 2 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
78531874 | 7853187 | 3 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40.0MG UNKNOWN | 0 | 40 | MG | CAPSULE | |||||||
78531874 | 7853187 | 4 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40.0MG UNKNOWN | 0 | 40 | MG | CAPSULE | |||||||
78531874 | 7853187 | 5 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40.0MG UNKNOWN | 0 | 40 | MG | TABLET | |||||||
78531874 | 7853187 | 6 | SS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40.0MG UNKNOWN | 0 | 40 | MG | TABLET | |||||||
78531874 | 7853187 | 7 | SS | ANASTROZOLE. | ANASTROZOLE | 1 | Oral | 0 | 1 | MG | TABLET | QD | |||||||
78531874 | 7853187 | 8 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
78531874 | 7853187 | 9 | C | PREVACID | LANSOPRAZOLE | 1 | 0 | ||||||||||||
78531874 | 7853187 | 10 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
78531874 | 7853187 | 11 | C | GLYCOPYRROLETE | 2 | 0 | 1 | MG | QD | ||||||||||
78531874 | 7853187 | 12 | C | LOSARTAN POT | LOSARTAN POTASSIUM | 1 | 0 | 50 | MG | QD | |||||||||
78531874 | 7853187 | 13 | C | REFRESH EYE DROPS | 2 | 0 | |||||||||||||
78531874 | 7853187 | 14 | C | CALCIUM CITRATE PLUS D3 | 2 | CALCIUM CITRATE PLUS D3 IS 500 IUS OF VITAMIN D3 WITH 630 MG OF CALCIUM | 0 | 2 | DF | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
78531874 | 7853187 | 1 | Gastrooesophageal reflux disease |
78531874 | 7853187 | 2 | Hiatus hernia |
78531874 | 7853187 | 3 | Gastrooesophageal reflux disease |
78531874 | 7853187 | 4 | Hiatus hernia |
78531874 | 7853187 | 5 | Gastrooesophageal reflux disease |
78531874 | 7853187 | 6 | Hiatus hernia |
78531874 | 7853187 | 7 | Breast cancer |
78531874 | 7853187 | 8 | Blood cholesterol increased |
78531874 | 7853187 | 11 | Irritable bowel syndrome |
78531874 | 7853187 | 12 | Hypertension |
78531874 | 7853187 | 13 | Dry eye |
78531874 | 7853187 | 14 | Osteoporosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
78531874 | 7853187 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
78531874 | 7853187 | Abdominal pain upper | |
78531874 | 7853187 | Anxiety | |
78531874 | 7853187 | Blood cholesterol increased | |
78531874 | 7853187 | Breast cancer | |
78531874 | 7853187 | Drug ineffective | |
78531874 | 7853187 | Dysphagia | |
78531874 | 7853187 | Lower limb fracture | |
78531874 | 7853187 | Off label use | |
78531874 | 7853187 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
78531874 | 7853187 | 3 | 201604 | 0 | ||
78531874 | 7853187 | 4 | 201604 | 0 | ||
78531874 | 7853187 | 5 | 20160427 | 0 | ||
78531874 | 7853187 | 6 | 20160427 | 0 | ||
78531874 | 7853187 | 7 | 20110704 | 0 |